Skip to main content
Search
Main content
Nature genetics
Published

Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk

Authors

Marta Perez-Alcantara, Sam J Washer, Yixi Chen, Juliette Steer, Daianna Gonzalez-Padilla, Joe McWilliam, David Willé, Nikolaos Panousis, Peep Kolberg, Elena Navarro-Guerrero, Kaur Alasoo, Hazel Hall-Roberts, Julie Williams, Sally A Cowley, Gosia Trynka, Andrew R Bassett

Abstract

Nat Genet. 2026 Nov 17. doi: 10.1038/s41588-026-02843-0. Online ahead of print.

ABSTRACT

Mounting evidence implicates microglia in neurodegeneration, but linking disease-associated genetic variants to target genes and cellular phenotypes is hindered by the inaccessibility of these cells. We differentiated 261 human induced pluripotent stem cell lines into microglia-like (iMGL) cells in pools with phenotypic (differentiation, phagocytosis and migration) and single-cell transcriptomic readouts. Burden analysis of deleterious variants detected 36 genes influencing microglial phenotypes. Expression quantitative trait locus (eQTL) analysis identified 7,121 eQTL-associated genes and 79 colocalizations across four neurodegenerative disease genome-wide association studies, half of which had limited prior evidence of causality. Integration of eQTL and phenotypic associations highlighted the role of disease-relevant variants, including LRRK2 and TREM2 acting through microglial phagocytosis. A coupled CRISPR screen identified a role for TREM2 in phagocytosis and highlighted the importance of cell type in the directionality of phenotypic effects. By contextualizing variant effects within iMGLs in different inflammatory states, we provide a comprehensive framework for interpreting the function of risk loci in neurodegenerative disorders.

PMID:43045849 | DOI:10.1038/s41588-026-02843-0

UK DRI Authors

Dr Hazel Hall-Roberts

Postdoctoral Researcher

Understanding the cellular consequences of Alzheimer's disease genetic risk

Dr Hazel Hall-Roberts

Prof Julie Williams

Group Leader

Understanding the genetics of Alzheimer's disease

Prof Julie Williams